[EN] HYDANTOIN DERIVATIVES AS INHIBITORS OF MATRIX METALLOPROTEINASES AND/OR TNF-ALPHA CONVERTING ENZYME (TACE)<br/>[FR] DERIVES D'HYDANTOINE EN TANT QU'INHIBITEURS DE METALLOPROTEINASES MATRICIELLES ET/OU DE L'ENZYME DE CONVERSION DE TNF-ALPHA (TACE)
申请人:BRISTOL MYERS SQUIBB CO
公开号:WO2004033632A2
公开(公告)日:2004-04-22
The present application describes novel hydantoin derivatives of formula (I) or pharmaceutically acceptable salt or prodrug forms thereof, wherein L, Z0, R1, R4, R5, and R11 are defined in the present specification, which are useful as inhibitors of matrix metalloproteinases (MMP), TNF-a converting enzyme (TACE), aggrecanase, or a combination thereof.